Therefore, the objectives of this study were to examine the expression of FFAR2 and SOCS3 genes in people with normal serum urate (SU), asymptomatic hyperuricemia (AH), AH with asymptomatic MSU crystal deposition (AH + MSU), inter-critical gout and gout flare. The gene discussed is SOCS3; the disease is hyperuricemia.